Peptide GV1001 Reverses Alzheimer’s Neurodegeneration in Mice
In a groundbreaking advancement in neurodegenerative disease research, scientists have identified a novel peptide, GV1001, derived from human telomerase reverse...
Diana Fleming is a Scienmag editorial specialist profile for Neurodegenerative Diseases coverage.
In a groundbreaking advancement in neurodegenerative disease research, scientists have identified a novel peptide, GV1001, derived from human telomerase reverse...
In a groundbreaking study published in BMC Pharmacology and Toxicology in 2026, researchers have unveiled promising neuroprotective properties of a...
In the evolving field of neurodegenerative disease research, understanding the psychosocial dynamics affecting patients remains a critical frontier. A recent...
In the evolving landscape of Parkinson’s disease research, a critical methodological challenge has emerged that threatens the integrity of survival...
In a groundbreaking advancement for the diagnosis of Parkinson’s disease (PD), researchers have pioneered a highly refined magnetic resonance imaging...
In a groundbreaking study poised to redefine our understanding of neurodegenerative diseases, researchers have uncovered compelling evidence linking the expression...
In a groundbreaking longitudinal study published in Alzheimer's Research & Therapy, researchers from Fujita Health University in Japan have demonstrated...
In a groundbreaking study poised to reshape our understanding of neurodegeneration in Parkinson's disease, researchers Kim, Cash, Martins, and colleagues...
In a groundbreaking study that shines new light on the neurochemical underpinnings of depression in Parkinson’s disease, researchers have identified...
In recent years, the quest for more effective and sensitive amyloid detection agents has gained significant momentum in the scientific...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine